VANCOUVER, British Columbia, Nov. 21, 2006 (PRIMEZONE) -- Zecotek Medical Systems Inc. (TSX-V:ZMS) (Frankfurt:W1I) today announced its 3D2D display has reached prototype demonstration stage. The first demonstration of its full-colour display took place in early November at Zecotek's new Singapore facilities to a delegation of senior engineers and executives of a Japanese electronics major. Demonstrations were also given to representatives of the Singapore Government. Additional demonstrations are planned for the coming weeks.
"We are very pleased that we have reached this significant milestone in our 3D display development. Particularly gratifying for Zecotek was the invitation by the Japanese electronics major for further business discussions," stated Dr. Faouzi Zerrouk, President and CEO.
Zecotek's Real-Time 3D2D Display System is a novel, proprietary display system for the visualisation of images and data. Based on the autostereoscopic principle, but with substantial patent-pending innovation, it represents a new generation of 3D displays. Meeting the requirements of both mass market and professional use, it is particularly powerful when applied to the field of medical imaging. Its design provides for multi-user, multi-view, freedom of movement, high resolution in both 3D and 2D modes, superior image dynamic range in 2D mode, 2D and 3D simultaneous displays, common brightness, compatibility with existing applications and designed to be cost competitive.
The inspection took place on-site at Zecotek's Singapore facility where the Real-Time 3D2D Display System display is presently undergoing product engineering and large screen prototyping.
About the Company
Zecotek Medical Systems Inc. is a market-driven, Canadian research and development bio-photonics company that is focused on creating advanced materials and integrated optoelectronic devices used in high resolution medical imaging, optical precision surgery, biopharmaceutical research, and 3D displays. The Company commercializes its technologies directly as well as through strategic alliances with leading OEM manufacturers and distributors. New pre-production facilities have been established in Singapore. Shares of Zecotek are listed for trading on the TSX Venture Exchange under the symbol "ZMS".
The Zecotek Medical Systems logo is available at http://www.primezone.com/newsroom/prs/?pkgid=3001
This press release contains forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For additional information on Zecotek Medical Systems and our technologies please see our website at www.zecotekmed.com.